Verrica Pharmaceuticals Inc. - VRCA
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Dec 30, 2025 | Interim CFO | A | A | 10,000.0 | 0.0 | 0.0 | 18,962.0 | View | |
| Nov 25, 2025 | CMO | P | A | 589.0 | — | — | 589.0 | View | |
| Nov 25, 2025 | CMO | P | A | 2,357.0 | 4.2425 | 9,999.57 | 2,357.0 | View | |
| Nov 25, 2025 | Interim CFO | P | A | 884.0 | — | — | 884.0 | View | |
| Nov 25, 2025 | Interim CFO | P | A | 3,536.0 | 4.2425 | 15,001.48 | 8,962.0 | View | |
| Nov 25, 2025 | Chief Operating Officer | P | A | 2,500.0 | — | — | 2,500.0 | View | |
| Nov 25, 2025 | Chief Operating Officer | P | A | 10,000.0 | 4.2425 | 42,425.0 | 21,000.0 | View | |
| Nov 25, 2025 | CEO and President | P | A | 23,577.0 | — | — | 23,577.0 | View | |
| Nov 25, 2025 | CEO and President | P | A | 94,311.0 | 4.2425 | 400,114.42 | 182,593.0 | View | |
| Nov 25, 2025 | — | P | A | 687,690.0 | — | — | 687,690.0 | View | |
| Nov 25, 2025 | — | P | A | 343,845.0 | — | — | 343,845.0 | View | |
| Nov 25, 2025 | — | P | A | 2,750,762.0 | 4.2425 | 11,670,107.79 | 3,348,372.0 | View | |
| Nov 25, 2025 | — | P | A | 1,375,380.0 | 4.2425 | 5,835,049.65 | 3,958,189.0 | View |